Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

IRDye800CW-labeled GPC3-targeted agent

A fluorescence imaging agent and an immunoconjugate comprised of a glypican 3 (GPC3)-targeting moiety conjugated to the near-infrared (NIR) fluorescent dye IRDye800CW, that can potentially be used for the imaging of GPC3-expressing tumor cells. Upon administration of the IRDye800CW-labeled GPC3-targeted agent, the GPC3-targeting moiety targets and binds to GPC3 expressed on tumor cells. Upon fluorescence imaging of the fluorophore IRDye800CW, the GPC3-expressing tumor cells can be visualized and detected. GPC3, a heparan sulfate proteoglycan and a member of the glypican family, is overexpressed on certain tumor cell types while minimally expressed on normal, healthy cells; GPC3 plays an important role in cellular proliferation and differentiation.
Synonym:anti-glypican-3-IRDye800CW
anti-GPC3-IRDye800CW
Search NCI's Drug Dictionary